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Abstract
Background: Plaque disruption with superimposed thrombus is the predominant mechanism responsible for the onset of
acute coronary syndromes. Studies have shown that plaque disruption and thrombotic occlusion are frequently separated
in time. We established the histopathological characteristics of material aspirated during primary percutaneous coronary
intervention (PCI) in a large consecutive ST-elevation myocardial infarction (STEMI) population.
Methodology/Principal Findings: Thrombus aspiration during primary PCI was performed in 1,362 STEMI patients. Thrombus
age was classified as fresh (,1 day), lytic (1–5 days), or organized (.5 day). Further, the presence of plaque was documented.
The histopathological findings were related to the clinical, angiographic, and procedural characteristics. Material could be
aspiratedin1,009patients(74%).Componentsofplaquewerefoundin395ofthesepatients(39%).Freshthrombuswasfound
in 577 of 959 patients (60%) compared to 382 patients (40%) with lytic or organized thrombi. Distal embolization was present
in 21% of patients with lytic thrombus compared to 12% and 15% of patients with fresh or organized thrombus.
Conclusions/Significance: Material could be obtained in 74% of STEMI patients treated with thrombus aspiration during
primary PCI. In 40% of patients thrombus age is older than 24 h, indicating that plaque disruption and thrombus formation
occur significantly earlier than the onset of symptoms in many patients.
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Introduction
Acute ST-elevation myocardial infarction (STEMI) is caused by
occlusion of a coronary artery as a result of coronary atherosclerotic
plaque disruption with superimposed luminal thrombus.[1] Many
plaque disruptions are initially covered by mural thrombi without
causing clinical symptoms. These mural thrombi may organize over
time, a process characterized by ingrowth of smooth muscle cells
and overgrowth of endothelial cells. Organized mural thrombi may
entirely be incorporated in the atherosclerotic lesion, whereby the
integrity of the vessel wall is restored. These so called healed plaque
ruptures are found very frequently in coronary arteries at
autopsy.[2–4] In other patients, atherosclerotic plaque disruption
with mural thrombosis leads to a process of repeated or ongoing
thrombosis,whichultimatelyresultsinanacutecoronarysyndrome.
We recently described the composition and age of aspirated
thrombi in a small cohort of STEMI patients treated with primary
percutaneous coronary intervention within 6 h of onset of
symptoms. We demonstrated that in approximately 50% of these
STEMI patients, coronary thrombi were days or even weeks
old.[5] The aim of the present study is to establish the
histopathological characteristics and age of material aspirated
during primary PCI in a much larger consecutive STEMI
population, to identify predictors of successful thrombus aspiration
and thrombus age, and to confirm the concept that there is a
heterogeneous time course of different processes leading to the
occlusive thrombotic event.
Materials and Methods
Setting
Our institution is a large referral hospital with an annual PCI
volume of 2,400 procedures, 600 of which are primary PCIs.
Patients are eligible for primary PCI when they have symptoms of
an acute STEMI accompanied by an electrocardiogram with ST-
segment elevation of $0.2 mV in two or more contiguous leads
and present within 12 hours after the onset of symptoms. PCI is
performed by standard techniques through the femoral or radial
route. Since August 2001, thrombus aspiration has been routinely
performed when technical feasible as determined by the operator.
Three different systems have been used: the 7F Rescue catheter
(Boston Scientific/Scimed, Inc, Maple Grove, Minn), the 6F
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Santa Rosa, CA), and the 6/7F Proxis
TM embolic protection
device (St. Jude Medical, St. Paul, MN). The choice of the
aspiration device is at the discretion of the operator. Pharmaco-
logic treatment before PCI includes the administration of aspirin
in a loading dose of 300 mg, unfractionated heparin 5,000–
10,000 IU, and clopidogrel in a loading dose of 300 or 600 mg.
The use of glycoprotein IIb/IIIa inhibitors and anti-thrombotic
medications is at the discretion of the operator. Clinical,
angiographic, and procedural characteristics of all PCI-procedures
are prospectively collected in an electronic database.
Study design
The study cohort consists of all patients in whom thrombus
aspiration was performed in adjunct to the conventional primary
PCI between August 2001 and January 2008.
Information about baseline characteristics (gender, patient age, risk
factors, cardiac history, medication, etc.), procedural characteristics,
angiographic characteristics (lesion length, bifurcation, chronic total
occlusion, stent implantation, procedural success), and the use of
thrombus aspiration devices (type of device, device passage,
angiographic result, material obtained) was obtained from the
electronic database. Angiographic characteristics such as distal
embolization, pre- and post-procedural TIMI flow, lesion length,
and residual stenosis have been prospectively recorded by the
operator by visual assessment immediately after the procedure. In this
study informed patient consent was not acquired, because thrombus
aspiration and the histopathological assessment of aspirated material
were part of routine clinical practice. In addition, because of the study
being part of routine clinical practice nor a formal waiver under the
description of Record-based Research from or approval by the local
Medical Ethical Committee were required for this study.
Aspirated material was fixed in formalin immediately after
thrombus aspiration and was sent to the department of cardiovas-
cular pathology. Material was fixed for at least 24 hours in 10%
neutral buffered formalin and embedded in paraffin. The paraffin
embedded material was serially sectioned, cut, and mounted on
glass slides at $6 levels. The sections were stained with
Hematoxylin and Eosin (H&E) for light microscopy. Histopatho-
logical analyses were performed by an experienced cardiovascular
pathologist (A vd W) while blinded to the clinical characteristics of
the patients, angiographic findings, and the result of the PCI-
procedure. The sections were analysed for the presence or absence
of aspirated material. If sufficient material was available ($1m m
2)
and thrombus was present, thrombus age was classified into 3
groups according to previously published and histopathologically
accepted definitions.[3,5,6] Fresh thrombus (less than 1 day) was
completely composed of layered patterns of platelets, fibrin,
erythrocytes and intact granulocytes. Lytic thrombus (between 1
and 5 days) shows areas of colliquation necrosis and karyorrhexis of
granulocytes. Organization of thrombus (more than 5 days) is
characterized by areas of ingrowth of smooth muscle cells, with or
without depositions of young connective tissue and ingrowth of
capillary vessels. Thrombus material with a heterogeneous
composition was graded according to the age of the oldest
components. Plaque was identified on the basis of either ‘‘soft
plaque’’ material (extracellulair lipids, macrophage foam cells, and
cholesterol crystals), calcific deposits, fibrous or fibro-elastic tissue,
or combinations of these components.
Statistical analysis
Continuous data were expressed as mean6standard deviation
and categorical data as frequencies, unless otherwise noted.
Differences between patient groups were tested with Student’s T
test or the Mann-Whitney U statistic test, as appropriate.
Categorical variables were compared with the use of Fisher’s
Exact test. Multivariate logistic regression models were performed
to identify independent predictors of the presence of aspirated
material and of thrombus age. Variables were entered if the p
value was less than .10 and removed if the p value was more than
.10. All tests were two-sided, and p values of less than 0.05 were
considered statistically significant. Statistical analysis was per-
formed with the Statistical Package for Social Sciences software
(SPSS 12.0 for Windows, SPSS Inc, Chicago, IL).
Results
Study cohort
Mechanical thrombus aspiration during primary PCI was
performed in 1,362 patients. Histopathologically confirmed
material was obtained in 1,009 patients (74%). In the remaining
353 patients (26%) material could not be identified (Figure 1).
Succesfully thrombus aspiration
Clinical, angiographic and procedural characteristics of the
patients with and without histopathologically confirmed material
are summarized in Table 1. Patients without aspirated material were
older compared to patients with aspirated material. Further, patients
without aspirated material more often had bifurcated and calcified
lesions (13.3% versus 9.0% and 19.3% versus 14.2%). The presence
Figure 1. Study flow chart.
doi:10.1371/journal.pone.0005817.g001
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patients with aspirated material (91.1% versus 90.1%, p=0.67).
Distal embolization occurred significantly less often in patients in
whom no material was aspirated (7.7% versus 14.7%, p=0.002).
Univariate analysis showed a significant association between the
presence of aspirated material and patient age, bifurcated lesions, and
calcified lesions. Multivariate analysis identified patient age (0.65
[95% CI 0.51 to 0.83], p=0.001) and occlusion of a bifurcation
lesion (0.65 [95% CI 0.44 to 0.95], p=0.024) as independent
predictors of the presence of aspirated material (data not shown).
Thrombus age
Thrombus could not be identified or thrombus could not be
classified according to age, in 50 of the 1,009 patients with
aspirated material. These patients were excluded from the analysis
(Figure 1). We identified a completely fresh thrombus in 577 of the
959 patients (60%). Lytic thrombus was found in 199 patients
(21%), 131 with only lytic thrombus and 68 with fresh and lytic
thrombus. Organized thrombus was found in 183 patients (19%),
68 with only organized thrombus, 44 with fresh and organized
thrombus, 40 with lytic and organized thrombus, and 31 with
fresh, lytic and organized thrombus (Table 2). In total, in 382 of
959 patients (40%) aspirated thrombi showed lytic or organized
changes signifying thrombus formation occurring significantly
earlier than the time of onset of symptoms.
Clinical, procedural, and angiographic characteristics of the
patients with fresh, lytic or organized thrombus are summarized in
Table 3. Total ischemic time (time between the onset of symptoms
and needle time) was significantly shorter in patients with fresh
thrombus (2.4 hrs versus 4.3 and 4.4 hrs, p=0.007). There were
no differences in door-to-needle time. Distal embolization
occurred in 12.1% of patients with fresh thrombus, in 21.2% of
patients with lytic thrombus, and in 15.2% of patients with
organized thrombus (p=0.007).
Univariate analysis showed a significant association between the
age of aspirated thrombus and total ischemic time. Multivariate
analysis identified a history of hypertension (1.31 [95% CI 0.98 to
1.75], p=0.072) and a longer total ischemic time (1.08 [95% CI
1.03 to 1.13], p=0.001) as independent predictors for the
presence of older thrombus (lytic or organized) (data not shown).
Plaque components
Components of plaque were found in 396 of the 1,009 patients
(39%) with aspirated material. In 31 patients (3%) aspirated
Table 1. Clinical, angiographic and procedural characteristics of the 1,362 patients treated with thrombus aspiration during
primary PCI.
Material obtained No material obtained P value
(n=1,009) (n=353)
Male 748 (74) 247 (70) 0.14
Age (years) 59613 62612 0.001
Diabetes mellitus 100 (10) 34 (10) 0.92
Hypercholesterolaemia 205 (20) 76 (22) 0.65
Current smoking 496 (49) 163 (46) 0.35
Hypertension 313 (31) 111 (31) 0.89
Previous MI 90 (9) 33 (9) 0.83
Previous CABG) 17 (2) 4 (1) 0.62
Previous PCI 64 (6) 21 (6) 0.90
Shock 118 (12) 37 (11) 0.56
Total ischemic time (h){ 3.763.4 3.863.2 0.32
Infarct related artery LAD 436 (43) 143 (41) 0.38
Pre-procedural TIMI flow 0–1
1 846 (85) 290 (84) 0.49
Multivessel disease
1 283 (27) 96 (28) 0.78
Lesion type class C{
1 353 (37) 127 (40) 0.42
Bifurcation
1 91 (9) 46 (13) 0.04
Ostial
1 74 (7) 20 (6) 0.33
Calcified
1 143 (14) 68 (19) 0.03
Lesion length (mm)
1 16.666.2 15.465.8 ,0.0001
Stent placement 937 (93) 326 (92) 0.72
Stent length (mm) 19.365.3 18.364.8 0.03
Stent diameter (mm) 3.660.5 3.460.5 ,0.0001
Post-procedural TIMI flow 3
1 898 (90) 314 (91) 0.67
Residual stenosis $20%
1 35 (4) 14 (4) 0.62
Distal embolization
1 147 (15) 27 (7) 0.001
Continous variables are presented as means and standard deviations and categorical data are presented as frequencies (counts) and percentages.
LAD=left anterior descending coronary artery; TIMI=Thrombolysis In Myocardial Infarction; 1=By visual assessment by the operator; {=Time between onset of
symptoms and needle time; {=According to the ACC-AHA classification.
doi:10.1371/journal.pone.0005817.t001
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plaque components could be identified in 365 patients (36%). In
the majority of the patients components of soft plaque were found
(339/395, 86%). Histological evidence of calcific deposits and
fibrous or fibro-elastic tissue was found in 105 (27%) and 104
patients (26%), respectively.
Table 2. Classification of thrombus age of aspirated material in 959 patients with classifiable thrombus material.
Thrombus age Patients Subcategory thrombus age Patients
(n=959) (n=959)
Fresh thrombus 577 (60)
Lytic thrombus 199 (21) Complete lytic thrombus 131 (66)
Fresh and lytic thrombus 68 (34)
Organized thrombus 183 (19) Complete organized thrombus 68 (37)
Fresh and organized thrombus 44 (24)
Lytic and organized thrombus 40 (22)
Fresh, lytic and organized thrombus 31 (17)
The categorical data are presented as frequencies (counts) and percentages.
doi:10.1371/journal.pone.0005817.t002
Table 3. Clinical, angiographic and procedural characteristics of the 959 patients with classifiable material.
Fresh thrombus Lytic thrombus Organized thrombus P value
(n=577) (n=198) (n=183)
Male 439 (76) 142 (72) 132 (72) 0.32
Age (years) 59613 61613 58614 0.07
Diabetes mellitus 58 (10) 20 (10) 14 (8) 0.60
Hypercholesterolaemia 117 (20) 43 (22) 35 (19) 0.81
Current smoking 288 (50) 98 (50) 93 (51) 0.98
Hypertension 192 (33) 60 (30) 50 (27) 0.28
Previous MI 43 (8) 23 (12) 15 (8) 0.19
Previous CABG 9 (2) 6 (3) 0 (0) 0.06
Previous PCI 39 (7) 13 (7) 10 (5) 0.82
Shock 64 (11) 23 (12) 27 (15) 0.42
Total ischemic time (h){ 3.362.4 4.064.3 4.264.4 0.007
Infarct related artery LAD 252 (44) 82 (41) 77 (42) 0.82
Pre-procedural TIMI flow 0–1
1 488 (86) 166 (86) 153 (85) 0.99
Multivessel disease
1 167 (29) 46 (23) 52 (28) 0.29
Lesion type class C{
1 205 (37) 69 (37) 60 (35) 0.90
Bifurcation
1 54 (9) 16 (8) 16 (9) 0.85
Ostial1 39 (7) 16 (8) 18 (10) 0.39
Calcified
1 89 (15) 28 (14) 18 (10) 0.21
Lesion length (mm)
1 16.566.5 17.065.6 16.666.1 0.61
Stent placement 539 (93) 177 (89) 175 (95) 0.07
Stent length (mm) 19.164.8 19.565.8 19.765.8 0.98
Stent diameter (mm) 3.660.5 3.660.5 3.560.5 0.10
Post-procedural TIMI flow 3
1 524 (92) 173 (88) 160 (88) 0.12
Residual stenosis $20%
1 18 (3) 11 (6) 4 (2) 0.14
Distal embolization
1 70 (12) 42 (21) 28 (15) 0.007
Continous variables are presented as means and standard deviations and categorical data are presented as frequencies (counts) and percentages.
LAD=left anterior descending coronary artery; TIMI=Thrombolysis In Myocardial Infarction; 1=By visual assessment by the operator; {=Time between onset of
symptoms and needle time; {=According to the ACC-AHA classification.
doi:10.1371/journal.pone.0005817.t003
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In this study we report the histopathological characteristics of
material obtained from a large consecutive cohort of STEMI
patients treatedwith thrombus aspiration inadjunctto conventional
primary PCI. Aspirated material could histopathologically be
confirmed in 74% of the patients. The obtained thrombus material
showed lytic or organized changes in 40% of the patients, indicating
the thrombus is older than 24 hours in a significant proportion of
STEMI patients with onset of symptoms less than 12 hours before.
We found older thrombus (more than one day) in a substantial
proportion of the STEMI patients (40%) and the composition of
the these thrombi was often heterogeneous, showing in part
features of fresh, of lytic, and organized thrombus. These results
support the concept of coronary artery disease as a dynamic
process. Disruption of atherosclerotic plaques may act as a
stimulus for repeated or ongoing thrombosis, which ultimately
progresses over a period of days or even weeks to thrombotic
occlusion with a secondary fresh thrombus. Systematic histopath-
ological analyses of the atherothrombotic material obtained with
thrombus aspiration during primary PCI in large patient cohorts
are limited. Our findings are in line with our previous results that
describe histopathological analyses of aspirated atherothrombotic
material in a smaller group of 211 STEMI patients in whom we
identified older thrombus in approximately 50% of patients.[5]
The insights in the mechanisms of coronary thrombosis mainly
come from detailed analyses of underlying plaque morphologies in
necropsy specimen from sudden death victims. Autopsy studies on
the histopathology of the progression of coronary plaques
demonstrated the occurrence of clinically silent coronary non-
occlusive atherothrombotic events before the occlusive athero-
thrombotic event.[2,7] Furthermore, multiple subclinical episodes
of plaque disruption, followed by healing, are an important
mechanism of atherosclerotic plaque growth.[2,4] A close
relationship has been demonstrated between the number of
previous plaque disruptions and the mean percentages stenosis in
the coronary artery.[2] Further, Henriques de Gouveia et al.
demonstrated that histopathological evidence of plaque instability
for some time was present in the majority of sudden coronary
death victims. They concluded that plaque disruption with
superimposed thrombus formation starts days or even weeks
before the time of death.[3] Subclinical episodes of plaque
disruption may have the potential to precondition the myocardi-
um. An alternative explanation is that several subclinical plaque
disruptions may results in the development of collateral vessels.
Therefore, patients with successive thrombotic occlusion after
several subclinical plaque disruptions may experience less acute
cardiac symptoms compared with patients in whom plaque
disruption immediately leads to a superimposed luminal thrombus
with total occlusion. This may explain why patients with lytic or
organized thrombus had a significantly longer total ischemic time
compared with patients with fresh thrombus (4.3 and 4.4 hrs
versus 2.4 hrs, p=0.007). Interestingly, distal embolization was
significantly different between patients with fresh, lytic or
organized thrombus, with the highest percentage in patients with
thrombus with lytic changes. Thrombus embolization may be less
frequent when the thrombus is fresh and fragile or when the
thrombus is organized and more solid and attached to the vessel
wall. This pathological finding is compatible with the report by
Kondo et al, who found an association between the no-reflow
phenomenon and a longer ischemic time.[8] These findings
suggest the presence of a time window of several days after plaque
disruption when distal embolization of thrombus is most likely to
occur in association with mechanical reperfusion.
In our study we aspirated atherothrombotic material in almost
three-quarter of the patients in whom an aspiration device was
used in adjunct to the conventional primary PCI. This is similar to
the 73% rate of histopatholgically confirmed material in the
EMERALD trial, the 73% rate in the TAPAS trial, and the 77%
rate with the use of the Proxis
TM embolic protection device.[9–11]
Several explanations have been proposed as to why atherothrom-
botic material could not be aspirated in all STEMI patients. The
aspiration devices may not have been efficient enough in
aspirating the atherothrombotic material. Alternatively, in some
patients with STEMI coronary occlusion may be caused by a non-
thrombotic lesion or a subtotal atherosclerotic plaque with
minimal thrombus. Consequently, in patients with lesions with
little or no thrombus and no aspirated material, distal emboliza-
tion was less frequent as in patients in whom material was
aspirated (14.6% versus 7.7%, p=0.001).
Study Limitations
Except for the TAPAS study, previous studies with thrombus
aspiration have been neutral or negative. Therefore, the use of a
thrombus aspiration device was non-standard clinical practice
during the study period and the decision to perform thrombus
aspiration was at the discretion of the operator. In some patients,
thrombus aspiration was not possible depending on coronary
anatomy, and in 353 patients no material was obtained. However,
we believe that there was no systemic selection of patients that
could influence our conclusions. Secondly, we cannot exclude the
possibility that atherothrombotic material was selectively aspirated
from the total of atherothrombotic material in situ. In our view,
this cannot be the sole explanation for the observed histopatho-
logical features of the aspirated thrombus. Thirdly, additional
immunostaining to optimize visualization of smooth muscle cells in
specimen of lytic or organized thrombus was not performed. The
major distinction in our paper, though, is fresh versus lytic or
organized thrombus, which is not affected by this limitation.
Finally, full information regarding anginal symptoms in the days
or weeks before the acute myocardial infarction was not available.
However, our previous thrombectomy study showed no clear
relation between thrombus age and the presence or absence of
preinfarction angina.
Conclusions
Our study shows that histopathologically confirmed material
could be obtained in almost three-quarter of a large consecutive
cohort of STEMI patients treated with thrombus aspiration during
primary PCI. Forty percent of the aspirated material showed
features of thrombus formation that occurred several days or even
weeks earlier, which confirms that there is an unpredictable time
span between onset of plaque disruption, thrombus formation, and
the onset of clinical symptoms of acute myocardial infarction. In
addition, our data suggest that there is a time window of several
days after plaque disruption in which thrombus embolization is
most likely. Knowledge of the composition and age of the
thrombus, perhaps with non-invasive imaging, might be helpful in
the future for the planning and choice of adjuvant therapy during
primary PCI.
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